Albertsons® Companies, Inc. (NYSE: ACI) (the "Company") today reported results for the first quarter of fiscal 2026, which ended June 20, 2026. Identical sales decreased 0.8% ...
Tadej Pogacar has essentially sewn up this year’s Tour de France – but what is it like managing a team trying to compete with ...
Some microorganisms that hold great promise for research have long lain dormant in historical collections. But only through ...
A FDA advisory committee will review evidence surrounding peptides. Experts are concerned there is a paucity of evidence to ...
PatientsLikeMe (“PLM”) Powered by Fuze Health, a leading patient engagement and health insights platform, and Science 37, the industry-leading patient access company for clinical research, today ...
The Centers for Medicare and Medicaid Services (CMS) has released the 2027 Medicare Physician Fee Schedule proposed rule. It includes ...
The FDA has approved Lipfendra, the first oral PCSK9 inhibitor, for the treatment of high cholesterol. Two medical experts explain why this matters.
From Indiana to Iceland, the FDA this week disclosed concerns raised during recent visits to a pair of manufacturing sites ...
Santa Clara-based Autonomous Healthcare has landed a coveted U.S. Food and Drug Administration De Novo marketing ...
HLB shares hit the daily upper limit Wednesday after the company said the FDA had closed a routine inspection of a rivoceranib active pharmaceutical ingredient (API) plant with a voluntary action ...
The standard narrative is that policing and imprisonment are necessary tools to keep the public safe from criminals. But it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results